Skip Navigation
Skip to contents

Scientific Program

Filter
SELECT AND VIEW SESSIONS OF YOUR CHOICE
Search

[JS05] Joint Session 05 (Asia Session)

Cross-Border Insights in NK/T-cell and T-cell Lymphoma: Perspectives from Japan, China, and Korea

Galaxy Theater
  • March 28 (Sat), 09:00-10:15
  • Deok Hwan Yang (Chonnam National University Medical School, Korea)
    Motoko Yamaguchi (Mie University Graduate School of Medicine, Japan)
  • 09:00-09:20 Current Practice and Research in T-cell and NK/T-cell Lymphoma in Japan Motoko Yamaguchi (Mie University Graduate School of Medicine, Japan) 09:20-09:40 Advances in the Diagnosis and Treatment of NK/T-cell Lymphoma: Perspectives and Team Experience Huangming Hong (Sichuan Cancer Hospital, China) 09:40-10:10 Clinical and Translational Research in T-cell and NK/T-cell Lymphoma in Korea Seok Jin Kim (Sungkyunkwan University School of Medicine, Korea) 10:00-10:15 Discussion

[SS14] Scientific Session 14

Germline Variants and Hematologic Malignancies: Current Understanding and Clinical Implications

Discovery Hall
  • March 28 (Sat), 09:00-10:15
  • Seongsoo Jang (University of Ulsan College of Medicine, Korea)
    Myung-Hyun Nam (Korea University College of Medicine, Korea)
  • 09:00-09:25 Ethnic Disparities in Germline Variants of Myeloid Malignancies Young-Uk Cho (University of Ulsan College of Medicine, Korea) 09:25-09:50 Inherited Myeloid Malignancies: From Genetic Diagnosis to Clinical Management Marc H.G.P. Raaijmakers (Erasmus MC Cancer Institute, The Netherlands) 09:50-10:15 Germline Predisposition Genes in Lymphoid Malignancies Susan L. Slager (Mayo Clinic, USA)

[SS15] Scientific Session 15

Exploring the Map of CML: Beyond BCR::ABL1

Universe Arena
  • March 28 (Sat), 09:00-10:15
  • Dong-Wook Kim (Eulji University School of Medicine, Korea)
    Hawk Kim (Ewha Womans University College of Medicine, Korea)
  • 09:00-09:25 Immunological Landscape of CML Kyung-Mi Lee (Korea University College of Medicine, Korea) 09:25-09:50 Translating Single-Cell Biology into Clinically Actionable Protein Biomarkers in CML Sin Tiong Ong (Duke-NUS Medical School, Singapore) 09:50-10:15 Drug Combination to Overcome Resistance in CML Delphine Rea (Saint-Louis University Hospital, France)

[ES07] Education Session 07

Preventive and Supportive Approaches in Hematologic Malignancies

Supernova Stage
  • March 28 (Sat), 09:00-10:15
  • Joon Seong Park (Ajou University School of Medicine, Korea)
    Hyo Jung Kim (Hallym University College of Medicine, Korea)
  • 09:00-09:25 Vaccination and Infection Prevention Seong Jin Choi (Seoul National University College of Medicine, Korea) 09:25-09:50 Cardiotoxicity: Risk Assessment and Prevention Hyukjin Park (Chonnam National University Medical School, Korea) 09:50-10:15 Chemotherapy-Induced Peripheral Neuropathy Young Woo Jeon (College of Medicine, The Catholic University of Korea, Korea)

[PL03] Plenary Lecture 03

Galaxy Theater & Discovery Hall
  • March 28 (Sat), 10:30-11:15
  • Je-Jung Lee (Chonnam National University Medical School, Korea)
  • 10:30-11:15 High-Risk Multiple Myeloma in 2026: Early Intervention, MRD-Driven Therapy, and Beyond Philippe Moreau (University Hospital of Nantes, France)

Go top

Go top

Hosted by
Supported by